Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.
about
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.
@ast
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.
@en
type
label
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.
@ast
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.
@en
prefLabel
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.
@ast
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.
@en
P2093
P2860
P1433
P1476
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.
@en
P2093
Byung Gyu Kim
Chang-Ki Min
Cheol-Kyu Jung
Ji-Young Lim
Jonghoon Park
Kwang-Ai Won
Seung-Wan Kang
Sung-Eun Lee
Tae Hun Kim
P2860
P2888
P356
10.1186/S12885-016-2285-2
P407
P577
2016-03-24T00:00:00Z
P5875
P6179
1023442080